ARTICLE | Company News
Corgenix Medical Corp., Genesis Bioventures deal
August 11, 2003 7:00 AM UTC
Anti-phospholipid test developer and manufacturer CONX and diagnostics company GBI signed a letter of intent to merge. GBI will issue 14 million shares for ownership of CONX, valuing the deal at about...